An Open-Label Study Investigating Differences Between Women and Men
This study will help to determine the drug dosing differences between men and women. The study will also document other notable gender differences. This is an opportunity for women and men to contribute tremendously to the AIDS research effort, be a part of the solution, and prolong the lives of PWA's.
If you have taken combinations without a protease inhibitor, d4t and/or ddI, you may be a good candidate for this trial.
There are 12 sites throughout the country. For enrollment information please call: 1.800.554.4876. (See article on The At Last Trial in this edition.)
UCLA -- 310.206.6414
Offers a wide variety of clinical studies for women, by a team of women researchers.
OI Therapies (UCLA)
Ganciclovir implant + oral ganciclovir vs. cidofovir for CMV retinitis.
Fluconazole for oral candida; chronic vs. episodic treatment.
For Pregnant Women (UCLA)
Study 321: Phase I, Safety, Tolerance and Pharmacokinetics of Abacavir (Ziagen) with standard AZT Therapy in new borns of HIV-infected women.
Study 326: Phase I & II - all babies will get AZT. Most will get a vaccine that might help them fight off HIV.
Study 331: to decide the best dose of AZT for premature infants exposed to HIV.
USC -- 213.343.8324
llame al 213.740.0299
A wide variety of clinical studies are open to women, including trials with antivirals and protease inhibitors. Also those looking to prevent and treat opportunistic infections.
La Escuela de asistencia social en la U.S.C. está llevando a cabo una encuesta de encuesta es completamente confidencial, y se paga $20.
Other Research Efforts
If you think you might have a recent exposure to HIV, give us a call -- 213.351.8195 ext.8175.
HIV+ Women Needed
Women ages 18-50 are needed for a study to measure the effects of testosterone replacement on body weight, and muscle mass. Incentive payments provided. Call: 310.222.8152.
Drug Resistance Testing
A study of a test that may determine sensitivity to antiretroviral treatment. It's open to women and men. Call Corie at 310.358.2429. Para informacion en Español, llame 310.360.3876.
Pain or Numbness
A 5-week study to see if gabapentin works for neuropathy. Everyone will receive medication. 310.358.2429.
World Wide Trial
Evaluation of ABT-378/ritonavir, a new protease inhibitor. This study is in the early phases. 1.800.313.2130.
Donate Your Brain
A project to study the effects of HIV on the brain. You must donate your brain after your death. 800.791.4966.
Phase II, double blind, placebo controlled. PMPA is a new antiretroviral drug being studied. Participants have an 85% chance of receiving drug. 310.358.2429.
This is only a partial list of the many clinical trials that are now available for women. If you are in search of a clinical trial please call Women Alive at 800.554.4876 and ask to speak with Laverne Mack. She will help you sort through the trials and find one that is right for you in your local area.